CHRONIC LUNG ALLOGRAFT DYSFUNCTION
Clinical trials for CHRONIC LUNG ALLOGRAFT DYSFUNCTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LUNG ALLOGRAFT DYSFUNCTION trials appear
Sign up with your email to follow new studies for CHRONIC LUNG ALLOGRAFT DYSFUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung transplant patients: drug may slow chronic rejection
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called belumosudil in adults who have chronic lung allograft dysfunction (CLAD) after a bilateral lung transplant. CLAD is a form of chronic rejection that slowly worsens lung function. The study compares belumosudil to a placebo, both given …
Matched conditions: CHRONIC LUNG ALLOGRAFT DYSFUNCTION
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New inhaled therapy aims to slow lung transplant rejection
Disease control Recruiting nowThis study tests an inhaled drug called LAM-001 in 30 lung transplant patients who have developed chronic rejection (BOS). Participants will inhale LAM-001 or a placebo daily for 48 weeks. The goal is to see if the drug is safe and can slow the decline in lung function.
Matched conditions: CHRONIC LUNG ALLOGRAFT DYSFUNCTION
Phase: PHASE2 • Sponsor: Steven Hays, MD • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can new scans catch lung transplant failure before It's too late?
Diagnosis Recruiting nowThis study tests whether advanced imaging techniques, including oxygen-enhanced MRI and hyperpolarized xenon MRI, can detect chronic lung allograft dysfunction (CLAD) earlier than standard lung function tests. CLAD is a common complication after lung transplantation that can lead…
Matched conditions: CHRONIC LUNG ALLOGRAFT DYSFUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Sean Fain • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
New scan could spot lung scarring early in fibrosis and cancer patients
Diagnosis Recruiting nowThis early-phase study is testing a new imaging agent called [68Ga]CBP8 to see if it can safely and accurately detect collagen buildup (scarring) in the lungs. Researchers will compare scans from healthy volunteers, lung cancer patients, and people with pulmonary fibrosis. The go…
Matched conditions: CHRONIC LUNG ALLOGRAFT DYSFUNCTION
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC